David Olson, an assistant professor in the UC Davis departments of Chemistry and Biochemistry and Molecular Medicine, is investigating whether sub-hallucinogenic doses of psychedelic compounds like LSD and dimethyltryptamine could lead to new treatments for depression, anxiety and related disorders without the unwanted hallucinogenic effects.

Read more here: https://www.universityofcalifornia.edu/news/changing-minds

Register here

Join the Zoom Webinar at the specified date and time: https://ucdavis.zoom.us/j/97467195152